Glen Frick

Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer’s Disease

Robert Martone, Hua Zhou, Kevin Atchison et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 157 citations

Life Sciences, Biochemistry, Pharmacology +17

Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension

Andreas Meisel, Djillali Annane, Tuan Vu et al. · Journal of Neurology · 2023 · 107 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Proliferative Signaling by Store-Operated Calcium Channels Opposes Colon Cancer Cell Cytostasis Induced by Bacterial Enterotoxins

Shiva Kazerounian, Giovanni M. Pitari, Fawad J. Shah et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 77 citations

Life Sciences, Oncology, Pharmacology +16

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder

Jeffrey H. Newcorn, Péter Nagy, Ann Childress et al. · CNS Drugs · 2017 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Triple-Bead Mixed Amphetamine Salts (SHP465) in Adults With ADHD: Results of a Phase 3, Double-Blind, Randomized, Forced-Dose Trial

Glen Frick, Brian Yan, Lenard A. Adler · Journal of Attention Disorders · 2017 · 28 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14